European Medicines Agency starts rolling review for adapted Comirnaty COVID-19 vaccine, EMA (published 15th June 2022)

This version of Comirnaty has been adapted to provide better protection against a specific variant/variants of SARS-CoV-2. Review will initially focus on chemistry, manufacturing& control,& then immune response& efficacy against Omicron subvariants as development progresses.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news